ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.62
0.96%
US Tech 100
18,064.80
0.02%
S&P 500
5,277.51
0.80%
US Dollar vs CAD
1.36525
0.00%
Bitcoin
67,751.06
0.04%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Cantabio Pharmaceuticals Inc (CE) (CTBO)

  7. Cantabio Pharmaceuticals Inc (CE) (CTBO) News

CTBO

Cantabio Pharmaceuticals (CE) (CTBO)

Cantabio Pharmaceuticals Inc (CE)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:CTBO
DateTimeSourceHeadlineSymbolCompany
06/21/20193:12PMEdgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
06/21/20193:09PMEdgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
06/21/20193:05PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
06/17/20191:20PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
05/24/20193:51PMEdgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
05/24/20193:36PMEdgar (US Regulatory)Information Statement - All Other (definitive) (def 14c)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
05/15/20194:43PMEdgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
05/15/20194:39PMEdgar (US Regulatory)Information Statements (revised) (prer14c)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
05/08/201912:05PMEdgar (US Regulatory)Information Statements (revised) (prer14c)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
05/08/201911:55AMEdgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
04/10/20192:14PMEdgar (US Regulatory)Statement of Ownership: Private Transaction (sc 13e3)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
03/22/20191:25PMEdgar (US Regulatory)Proxy Statement - Other Information (preliminary) (pre 14c)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
03/21/20192:02PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
12/14/20181:27PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
11/13/201811:56AMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
10/15/20189:25AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
10/11/20184:08PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
10/11/20184:05PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
10/11/20184:02PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
08/20/20182:55PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
08/15/20189:09AMEdgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
07/16/20185:02AMEdgar (US Regulatory)Annual Report (10-k)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
06/29/20189:54AMEdgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
06/08/20189:21AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
04/11/20189:33AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
02/20/201811:42AMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
02/14/20182:17PMEdgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
11/27/201711:41AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
11/14/20171:56PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
08/14/20172:22PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:CTBOCantabio Pharmaceuticals Inc (CE)
 Showing the most relevant articles for your search:USOTC:CTBO

Your Recent History

BIT
UB3CW8
Unicredit Bank
USOTC
PPWLO
PacifiCorp (PK)
UNSW3
OPEPEETH
Ordinal Pepe
USOTC
UBSFF
UBI Soft Entertainment (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved